Eyetracking during picture naming predicts future vocabulary dropout in progressive anomia.
Jamie Reilly, Maurice Flurie, Molly B Ungrady
PMID 33115336WHAT IT FOUND
In patients with progressive language loss, eye-tracking during picture naming predicted which words would later be lost.
Words that would eventually drop out caused more scattered gaze and more fixations even when named correctly at baseline. This suggests gaze patterns could help identify vulnerable words for maintenance therapy.
Key findings
01Patients with progressive anomia showed no decline in naming accuracy for trained items over the study period, but did show a significant decline for untrained items.
02Words that were later lost from the patient's vocabulary (vulnerable words) elicited significantly more diffuse gaze patterns and a higher number of fixations during baseline naming compared to words that were retained.
03The study authors explicitly state it is premature to use eye gaze as a clinical biomarker due to limitations in experimental control and sample size.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Very small sample size (N=10) with only seven patients providing complete data, increasing the risk of bias and outlier influence. Heterogeneous patient population (svPPA, lvPPA, and AD) which may limit generalizability to specific diagnostic groups. Home-based testing with portable eye-tracking resulted in lower data fidelity compared to laboratory settings. Stimuli were personalized and not rigorously matched for visual complexity, which is a known driver of fixation count. The study was retrospective in its classification of words, and the authors explicitly state it is premature to claim clinical utility.
Declared interests
The authors declare no conflicts of interest. The study was approved by institutional review boards at Temple University and the University of Pennsylvania.
The easy way to misread this
Do not implement eye-tracking as a clinical tool for selecting treatment targets based on this study. The authors state it is premature to tout gaze as a biomarker, and the findings rely on a small, heterogeneous sample with uncontrolled visual complexity in the stimuli.